Resultados de búsqueda - Andrew A. Grimm

  • Mostrando 1 - 6 Resultados de 6
Limitar resultados
  1. 1
    Assessing the therapeutic potential of lab‐made hepatocytes

    Assessing the therapeutic potential of lab‐made hepatocytes por Milad Rezvani, Andrew A. Grimm, Holger Willenbring

    Publicado 2016
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells

    The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells por Javier R. Revollo, Andrew A. Grimm, Shin‐ichiro Imai

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Glycogen Storage Disease Type Ia: A Retrospective Claims Analysis of Complications, Resource Utilization, and Cost of Care

    Glycogen Storage Disease Type Ia: A Retrospective Claims Analysis of Complications, Resource Utilization, and Cost of Care por Eliza Kruger, Justin Nedzesky, Nina A. Thomas, Jeffrey Dunn, Andrew A. Grimm

    Publicado 2025
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice

    Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice por Kathryn A. Moynihan, Andrew A. Grimm, Marie M. Plueger, Ernesto Bernal–Mizrachi, Eric L. Ford, Corentin Cras‐Méneur, M. Alan Permutt, Shin‐ichiro Imai

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study

    Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study por Samuel A. Kocoshis, Russell J. Merritt, Susan Hill, Susan Protheroe, Beth A. Carter, Simon Horslen, Simin Hu, Stuart S. Kaufman, David F. Mercer, Mikko P. Pakarinen, Robert S. Venick, Paul W. Wales, Andrew A. Grimm

    Publicado 2019
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis

    In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis por Milad Rezvani, Regina Español‐Suñer, Yann Malato, Laure Dumont, Andrew A. Grimm, Eike Kienle, Jay G. Bindman, Ellen Wiedtke, Bernadette Y. Hsu, Syed Naqvi, Robert F. Schwabe, Carlos U. Corvera, Dirk Grimm, Holger Willenbring

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: